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Abstract  
 
Background Little attention has been paid to the question of how to finance the costs of scaling 
up MNCH care and the likely availability of funds.  
Methods Past health expenditure (2000 – 2005) was analysed through the National Health 
Accounts of 57 high priority countries. We projected likely availability of funding for the period 
2006 – 2015 under two scenarios (business as usual and public commitments). We estimated the 
financing gap by comparing the share of projected total health expenditure dedicated to MNCH 
with the WHO costing model for scaling MNCH interventions.  
Findings The vast majority of countries spent less than 50 US$ per person on health in the year 
2005.  Under the business as usual scenario, the financing gap for the period 2006-2015 for low 
income countries is more than US$ 38.5 billion. Under the public commitments scenario, the gap 
for low income countries (excluding India) falls to just under US$ 18.3 billion.  
In lower middle and upper middle income countries the projected financing is estimated to meet 
costs under both scenarios. 
Interpretation The volume of financing resources for the majority of low income countries will 
not be adequate to meet MDGs 4 and 5, even under optimistic assumptions.  The financing 
sources required to “fill the gap” will depend on country context and needs.  Additional funds 
need to be effectively targeted to MNCH services.  Lower and upper middle income groups are 
likely to have sufficient funds. Their domestic policies for MNCH fund allocation will be 
paramount. 
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1. Introduction 
 
1.1 Background  
 
There is considerable concern that maternal, newborn and child health (MNCH) has not received 
sufficient attention in recent years in global health strategies and resource allocation decisions. 
The fourth Millennium Development Goal demands a reduction of two-thirds in under five 
deaths between 1990 and 2015, and the fifth goal a reduction of three-quarters in maternal 
mortality.  Child mortality rates have been falling in low income countries, but not fast enough to 
meet the 2015 target and neonatal mortality has to be addressed if further progress is to be made 
[1] [2]. The least progress has been made towards the maternal mortality goal. While many 
regions have seen modest reductions in the maternal mortality ratio, Sub-Saharan Africa 
represents the greatest challenge, with no signs of progress [3]. 
 
It is well recognised that increasing coverage of the most cost-effective interventions is key to 
achieving MDGs 4 and 5.  Recent studies have estimated the costs of scaling-up maternal, 
newborn and child health care to achieve universal coverage of key interventions by 2015 [4, 5].  
In addition, current resource flows to MNCH from donor agencies has also been estimated [6].  
However, in order to assess how much more is required to achieve the scale-up, it is necessary to 
address the ‘financing gap’ – the difference between what is required to scale-up MNCH services 
and projected future expenditure. 
 
1.2 Objectives  
 
The objectives of the present study were twofold.  First, past health expenditure trends were 
analysed and levels of total health expenditure projected over the period 2006-2015 according to 
two scenarios. Second, we estimated the financing gap between the cost of achieving MDGs 4 
and 5 and the projected spending on maternal, newborn and child health.  
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2. Methods 
 
2.1 List of countries  
 
Expenditure and cost estimates were analysed for 60 priority child survival countries.  These 
countries represent almost 500 million children – more than 75% of children under five in 2004 - 
and account for 94% of all deaths among children under five in the world [7].  The list of 
countries was based on two selection criteria. The first ensures countries are selected according to 
their total number of child deaths in the year 2003. All countries suffering at least 50,000 child 
deaths were included.  The second was the under five mortality rate. Any country not already 
selected from the first list that has a rate of at least 90 under five deaths per thousand live births 
were chosen for our analysis. The second list ensures that countries with a small population but 
high child mortality rates (for example many Sub-Saharan African countries) are taken into 
consideration. The selection of countries, while not based on any maternal health criteria, does 
contain the majority of the countries in the greatest need with respect to maternal health1.  
 
The list of the 60 selected countries is provided in Annex 1.  Due to the absence of reliable data 
for three of these countries (Zimbabwe, Iraq and Somalia), the analysis was conducted on 57 of 
the 60 countries. 
 
2.2 Defining health expenditure  
 
For the purpose of this study, the definitions and classification of general government 
expenditure and health expenditure were those used by the System of National Health Accounts, 
the internationally accepted methodology to track health resources within a country [8]. A 
description and definition of terms used are provided below.  
                                                 
1 Of the 60 countries ranked with the highest maternal mortality ratio per 100 000 live births (according to WHO 
http://www.who.int/whosis/whostat2006/en/index.html ), 10 are not included in the selection: Bhutan, Bolivia, 
Comoros, Eritrea, Guatemala, Laos, Lesotho, Namibia, Peru, Timor-Leste  
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Financing sources are entities that provide health funds, and financing agents are entities which 
manage the funds. They receive funds from financing sources and use them to pay for health 
services, products (e.g. pharmaceuticals), and activities [9].  Health expenditures are 
conventionally measured by the WHO in terms of financing agents but for projecting future 
expenditure, we define these at the level of financing source. Expenditures by financing agent are 
classified as follows:  
 
General government expenditure (GGE) corresponds to the consolidated outlays of all levels 
of government; territorial authorities (Central/Federal Government, 
Provincial/Regional/State/District authorities, Municipal/ Local governments), social security 
institutions, and extra-budgetary funds, including capital outlays. 
General government health expenditure (GGHE) is the sum of outlays on health paid for by 
taxes, social security contributions and external resources (avoiding double-counting the 
government transfers to social security and extra-budgetary funds).  
Private health expenditure (PvtHE) comprises the outlays of insurers and third-party payers 
other than social security, mandated employer health services and other enterprise-provided 
health services, non-profit institutions and non-governmental organisations financed health care, 
private investments in medical care facilities and household out-of-pocket spending.  
Externally funded health expenditures are loans and grants for medical care and medical goods 
provided by entities outside of the recipient country. Grants in-kind (capital equipment, 
pharmaceutical supplies and vaccines, technical assistance such as experts) should be estimated 
in terms of their monetary value. 
 
2.3 Defining maternal, newborn and child health  
 
Expenditures on child health were defined as expenditures on those activities whose primary 
purpose is to restore, improve, and maintain the health of children during a specified period of 
time and that are delivered directly to the child. Children are defined as those aged between 1 
week and 5 years (under 5). Maternal and neonatal health expenditures were defined as 
expenditures on those activities whose primary function is to restore, improve, and sustain the 
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health of women and their newborn during pregnancy, childbirth, and the 7-day post partum 
period. Resources for single activity or interventions are not easy to track, as accounting systems 
of donor organisations are not often designed to identify expenditures on different activities 
within a project [6].  
 
2.4 Sources of data 
 
The principal sources of data for gross domestic product (GDP), inflation (consumer prices index 
– CPI) and exchange rates were the World Economic Outlook Database [10] and the International 
Financial Statistics [11]. Actual population and projections were taken from the UNPOP website 
[12]. 
 
The principal source of data on General Government Expenditure, and General Government 
Expenditure for Health, was the World Health Organisation’s National Health Accounts 
database[13]. WHO provide health expenditure data at the level of financing agent.  Values 
provided by WHO and the IMF are in national currency units (millions). In order to standardize 
the findings across different countries and years, we converted nominal values into real data 
using 2004 as a base year.  Subsequently, we converted values into US$ at the exchange rate 
provided by the IMF. Therefore, the projected expenditures between 2006 and 2015 are presented 
in 2004 constant prices.  The consumer price index for each country was used to generate real 
values thereby taking into account inflation. 
  
The estimates of external resources to maternal, newborn, and child health were derived from 
various sets of data, including the DAC and CRS databases, provided by the Organisation for 
Economic Co-operation and Development (OECD). The databases capture the resource flows 
from bilateral donor agencies, multilateral development organisations, and global health 
initiatives. They include all 22 high-income donor countries and the European Union, represented 
in the Development Assistance Committee of the OECD, a forum for the major bilateral donors 
of ODA. Additionally, they include the World Bank, UNICEF, and the UN Population Fund 
(UNFPA) as multilateral development organisations; and more recently the Global Alliance for 
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Vaccines and Immunisation (GAVI) and the Global Fund to fight AIDS, Tuberculosis and 
Malaria (GFATM) as global health initiatives [6].  The methods we use to make projections 
account for resources coming from UNITAID and the Gates Foundation (channelled through 
GAVI only).  
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3. Data analysis  
 
We constructed spreadsheet models to project likely trends of financial flows to MNCH over 
time. We adopted a highly simplified financing structure for each country, distinguishing 
between three sources of funding: government expenditure, private expenditure and external 
assistance. The projections are made annually, starting in 2006 and covering the period up to 
2015.  
 
The analysis consisted of the following steps:   
i) We analyzed the public and private composition of total and per capita health 
expenditure over the period 1998 – 2005 to explore recent trends in total expenditure 
for health.  
ii) We triangulated NHA data on external spending with estimates of donor 
disbursements to provide a comprehensive picture of financing to health in the high 
priority countries for the base year 2005.  
iii) We projected the three components of total health expenditure (public, private and 
external) from 2006 to 2015 under two different scenarios. 
iv) We estimated recent country spending on maternal, newborn and child health using 
methods of apportionment. The analysis was carried out on a country-by-country 
basis.  However, the results are presented by income group using the World Bank 
classification of low, low middle and upper middle income and by region using the 
World Bank geographical classification.  Given the high rates of economic growth of 
China and India, the results are presented both including and excluding these two 
countries. 
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3.1 Assumptions  
 
There are inherent uncertainties in modelling future trends, and assumptions based on the 
available evidence must be made. We modelled health expenditure trends under two different 
scenarios, as defined below:  
 
Business as usual – this scenario assumed that expenditure for MNCH would increase in 
line with current trends.  General Government Health Expenditure projections were based 
on past trends from 1998 to 2004, assuming that growth in GGE for Health would be 
stable at an average of previous years. ODA projections were based on the past trends of 
ODA disbursements between the previous two years (2003 and 2004) 
 
Public commitments – this scenario assumed that expenditure for MNCH would increase 
in line with public commitments.   General Government Health Expenditure projections 
were based on the public announcement made by African Heads of State in the Abuja 
Declaration [14], that GGE for Health should grow to 15% of GGE by 2015. ODA 
projections were based on the announcements made at the G8 in 2005. These 
commitments, for the majority of countries, have been made only up to 2010. It was, 
therefore, assumed that ODA as a proportion of DAC country GDP would remain 
constant over the period 2011-2015 at the percentage announced, or it would grow up to 
0.7% in 2015, whichever share is higher. It was not realistic to apply this assumption to 
the US and Japan as their commitments were lower. Their share is therefore projected to 
reach 0.3% in 2015. For further details, see annex 2.  
 
Table 1 summarises the key assumptions regarding projections of total health expenditure under 
each scenario.  Additional assumptions that apply equally to both scenarios are described further 
below.  In order to forecast real GDP, we applied country specific growth rates provided in the 
World Bank Global Economic Prospects up to the year 2008 [15]. For the years 2009 to 2015 we 
use real GDP projections based on regional growth rates provided by the same source (country 
specific projections are not available) [15].  We assumed annual real GDP growth for DAC 
countries to be in line with OECD projections in 2007, and 2 percent thereafter[16].   
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The share of government expenditure in real GDP over the period 2006-2015 was assumed to be 
constant and was based on the average between 2000-2005 [13]. Private spending was assumed 
to increase in line with real GDP growth. 
 
Estimates of government and private health expenditure provided by WHO are measured in terms 
of financing agents, with public and private health expenditure each including a share of 
externally sourced health expenditure. For our purposes, we are interested in health expenditure 
at the level of financing source since our assumptions are specific to each of the three types of 
financing source. To derive public and private health expenditure at the level of financing source, 
we therefore need to subtract a share of external funds from the financing agents.  Data from 
NHA exercises undertaken in 10 of the 60 priority countries2 provided an indication of the 
proportion of externally financed health expenditure that is managed by public and by private 
entities at the level of financing agent. We assumed that 70% of external funds are allocated to 
government financing agents and 20% to private financing agents, the average from 1998. It is 
worth noting that the allocation only affects the composition of health expenditure, and it is not 
relevant for the forecasted availability of financial resources as a whole.   
It was further assumed that the distribution of ODA across recipient countries and across sectors 
would remain the same as in year 2004.  
 
Finally, assumptions were required to determine the maternal and child health proportion of total 
health expenditure. For external health expenditure we estimated that the proportion of total ODA 
spent on maternal, newborn and child health is 28%, using data from an analysis of donor 
spending on health [6]. For private and public health expenditure, the only data available are 
provided by NHA sub analyses of MNCH in four countries (Bangladesh 19%, Egypt 14%, 
Morocco 16% and Sri Lanka 11%), two of which are not in our selection of priority countries. 
We estimated the proportion as 15% of total health expenditure, based on the average of the 
available NHA sub analyses.  
 
                                                 
2 The countries with NHAs that provide the public and private shares of allocation of externally financed health 
expenditure are Egypt (6% 94%), Kenya (36% 64%), Malawi (33% 67%), Niger (0% 100%), Rwanda (65% 35%), 
Tanzania (9% 91%), Uganda (55% 45%), Yemen (19% 81%), Zambia (25% 75%), Zimbabwe (24% 76%)  
 13
Table 1. Key assumptions for projecting total health expenditure 
 
Variables Scenario 1 Business as usual 
Scenario 2 
Public commitments Source 
Annual real GDP growth 
rate of priority countries  
Up to year 2008: country specific 
Years 2009 - 2015: regional 
World Bank Global 
Economic Prospect [15] 
Annual real GDP growth 
rate of donor countries 2% OECD – DAC [16] 
General Government 
Expenditure as % of GDP Average 2000 – 2005 WHO [13] and IMF [10] 
General Government 
Expenditure for Health as 
% of General Government 
Expenditure  
Average 2000 – 2005 Increases up to 15% in 2015 WHO [13]  
Abuja 
Declaration 
[14] 
Private Health Expenditure  Increases in line with GDP growth  Best guess 
External Health 
Expenditure distribution 
amongst public and private 
financing agents 
70% for public agents 
30% for private agents  
Average based on 
available NHA reports 
[13] (see note 2) 
ODA as % of GDP  Average 2003 – 2004 
In 2015, 0.7% of 
GDP or the % 
committed in 2010 
(which ever higher) – 
except Japan and 
USA  
Distribution of ODA across 
priority countries  Constant as 2004 
Distribution of ODA across 
purpose activities  Constant as 2004  
OECD – DAC [16] 
MNCH as % of General 
Government Expenditure 
for Health 
15%  
MNCH as % of Private 
Expenditure for Health 15%  
Average of available 
NHA reports [13] 
(Bangladesh, Egypt, 
Morocco and Sri Lanka) 
 
MNCH as % of External 
Expenditure for Health  28%  [6] 
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3.2 Cost of scaling up maternal newborn and child health  
 
 
In the financial gap analysis, the aim was to compare our projected spending on MNCH with the 
costs of scaling-up MNCH coverage.  We used the cost estimates provided by WHO [4, 5]. 
Based on WHO clinical guidelines, the WHO costing model estimated additional maternal, child 
and newborn health care resource needs for the 60 priority countries, as incremental to current 
(2005) investments. Thus, expenditures required to maintain current coverage levels until 2015 
were not included.  
 
The analysis of the financing gap was carried out on an annual basis to show the yearly gap.  In 
order that the projections of health expenditure be comparable with the WHO cost estimates, the 
difference between yearly expenditure and expenditure in 2004 was derived as additional yearly 
health expenditure. 
 
The model for scaling up maternal and newborn health interventions estimated the costs for 
health care during pregnancy, childbirth, the newborn period, and postpartum period, including 
also family planning and counselling, abortion and post abortion care.  Patient costs such as 
drugs, vaccines, lab tests and medical supplies were included along with programme costs, such 
as the investments needed to strengthen health system infrastructure and upgrade existing health 
centres to hospital standard, train existing human resources, manage and support service 
provision to ensure quality of care, and promote accessibility to and demand for MNCH care.  
 
This costing exercise did not include increases in staff salaries and incentives to retain health 
workers in underserved areas.  No new hospitals were assumed to be built; it was assumed that 
additional activities with increased care could be carried out by renovating and upgrading 
infrastructure capacity (e.g. upgrading heath posts to health clinics, as well as upgrading health 
clinics to be able to perform comprehensive obstetric and neonatal emergency care).  [4, 5]. 
 
The prices used to estimate costs were derived from public sector providers. The projections were 
made in constant US$ (2004).  
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3.3 Sensitivity analysis  
 
In addition to the two scenarios outlined above, we also performed a series of one-way sensitivity 
analyses around the most uncertain parameters.  We considered the percentage impact on the 
financing gap (under business as usual) of a two percentage point change in GDP growth; of a 
five percentage point change in the share of total health expenditure going to MNCH (in line with 
the minimum and maximum values in the NHA reports); and a fifty percent increase in the costs 
of scaling up MNCH care share of total health expenditure going to MNCH (to account for salary 
increases and investments in new infrastructures for health care).   
  
A best case and a worst case scenario were also estimated to give an idea of the extreme lower 
and upper limits likely to surround the baseline financing gap estimate.  For the best case 
scenario, we considered the public commitments scenario, combined with a 2 percentage point 
increase in GDP growth, and a 5 percentage point increase in the share of total health expenditure 
going to MNCH.  For the worst case scenario, we considered the business as usual scenario 
combined with a 2 percentage point reduction in per capita GDP growth, a 5 percentage point 
decrease in the share of total health expenditure going to MNCH and a 50% increase in costs. 
 
 
4. Results  
4.1 Past Trends in Total Health Expenditure (2000 – 2005) 
 
We analysed past trends in health expenditure over the period 2000 - 2005, and its composition 
by public and private financing agents. Whilst there was a general increase in real total health 
expenditure during this period, there was considerable variation in the percentage change of 
government and private expenditure across countries (Figure 1). Twenty-one countries observed 
a decrease in total health expenditure. Decreases of over 50% over the period 2000-2005 were 
observed in DR Congo, Angola, Haiti and Guinea. Some countries like Burundi, Madagascar, 
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Brazil, Sierra Leone, Tanzania and Ethiopia experienced a net decrease in total health 
expenditure due to a drop in private sector expenditure, that was not compensated for by the 
relatively small increase in government expenditure.    
 
As figure 2 illustrates, the vast majority of the priority countries spent less than 50 US$ per 
person on health in the year 2005.  Overall, more than half of total health expenditure in low 
income countries is managed by the private sector and the poorer the country, the larger the share 
of private health expenditure. In countries like Myanmar, India, Cote d’Ivoire and Togo more 
than 80% of health resources are managed by private entities, implying that out-of-pocket 
payment is the major source of spending for health. The public share of per capita health 
expenditure varies with income level. Health expenditure managed by public sector entities 
represents around 41% of per capita health expenditure in low income countries, 50% in lower 
middle income countries and 60% in upper middle income countries.  
 
It is important to note that problems of data quality and consistency will affect the extent to 
which these trends depict the true situation.      
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Figure 1. Percentage change in real government and private health expenditure over the period 2000 – 2005 
(ranked by total health expenditure percentage change)  
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Figure 2. Real total Health Expenditure per capita in the year 2005 in US$ (2004 prices) (ranked by income 
groups and by total health expenditure)  
 
4.2 Health expenditure projection 2006 – 2015  
 
Under the business as usual scenario, per capita total health expenditure in low income countries 
will grow from US$ 27 in 2006 to US$ 34 in 2015. Around 77 percent of this amount will come 
from private sources in 2015, and only US$ 1 per person (4 % of total health expenditure) will 
come from external aid (see figure 3). For lower middle income countries, per capita total health 
expenditure will grow from US$ 102 in 2006 to US$ 146 in 2015. External aid accounts for less 
than 1 percent of the total.  For upper middle income countries per capita total health expenditure 
will grow from US$ 443 in 2006 to US$ 510 in 2015 and its composition by source is similar to 
that of lower middle income countries (see figure 4). 
 
Under the public commitments scenario, per capita total health expenditure in low income 
countries is projected to reach US$ 59 per person in 2015. Public disbursement is estimated to 
grow to US$ 30 per person (from 24 percent to 51 percent of the total), spending from private 
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sources is estimated to fall from 71 percent to 45 percent and external aid will increase to US$ 3 
per person (4 percent of total health expenditure) in 2015 (see figure 5).   
   
Per capita total health expenditure for lower middle income and upper middle income countries is 
assumed to grow respectively to US$ 179 and US$ 573 in 2015. Private funds are estimated to 
decrease to around a half of total health spending; public and external spending will increase 
slightly (see figure 5). 
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Figure 3. Real per capita Total Health Expenditure for low income countries under business as usual 
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Figure 4 Real per capita Total Health Expenditure for all income groups under business as usual in US$ 
(2004) 
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Figure 5. Real per capita Total Health Expenditure for low income countries under public commitments 
scenario 
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Figure 6. Real per capita Total Health Expenditure for all income groups under public commitments scenario  
 
4.3 The financing gap  
 
As stated above, the financing gap is derived by comparing estimated trends of additional 
incremental funding likely to be available over time with WHO’s costing of additional 
incremental funding required annually up to 2015, with both increments assessed against the 
baseline of 2005. As illustrated in figures 7 and 8, the low income group has to bear the greatest 
amount of estimated financial requirements and enjoys the lowest total amount of projected 
financing. 
Under the business as usual scenario (figure 7), the financing gap for the period 2006-2015 for 
low income countries is estimated to be more than US$ 38.5 billion. The resources gap is 
calculated at US$ 2 per person (US$ 5 excluding India) in the year 2015. Under the public 
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commitments scenario (figure 8), the additional MNCH expenditure for low income countries is 
estimated to meet WHO costs. But the average masks a huge variation; excluding India from the 
analysis, there is a financing gap of just over US$ 18.3 billion, or per capita US$ 2 in the year 
2015. 
 In lower middle and upper middle income countries the projected financing is estimated to meet 
costs under both scenarios. 
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Figure 7. Comparison by income group of projected additional incremental MNC health expenditure and 
WHO costs of scaling up MNCH 2006 – 2015 under business as usual in million US$ (2004)  
 
Income group Total additional MNCH expenditure Gap 
WHO costs for 
MNCH 
Low income  28,054 -38,508 66,562 
Low income w/o india 7,080 -34,341 41,421 
Lower middle income  101,350 78,688 22,662 
Lower middle income w/o china 25,744 13,491 12,253 
Upper middle income  11,936 5,091 6,845 
Table 2 the financing gap under business as usual  in million US$ (2004)   
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Figure 8. Comparison by income group of projected additional incremental MNC health expenditure and 
WHO costs of scaling up MNCH 2006 – 2015 under public commitments in million US$ (2004)   
 
 
 
Income group Total additional MNCH expenditure Gap 
WHO costs for 
MNCH 
Low income  73,651 7,089 66,562
Low income w/o india 23,135 -18,286 41,421
Lower middle income  157,894 135,232 22,662
Lower middle income w/o china 57,552 45,299 12,253
Upper middle income  21,891 15,045 6,845
Table 3 the financing gap under public commitments in million US$ (2004)   
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On a yearly basis, the financing gap is forecast to increase each year for low income countries 
(when India is excluded) under both scenarios. Over time lower and upper middle income 
countries are increasingly able to meet the costs of MNCH, with total health expenditure 
exceeding costs by a growing amount.  
 
We ran the analysis by regional grouping, and it is important to note that Sub-Saharan Africa 
countries are estimated to face a financial gap under both scenarios (figures 9 and 10). In the year 
2015 it is estimated that under the business as usual scenario, Sub-Saharan African countries will 
need US$ 4 per person in addition to available resources to cover the costs for that year. Under 
the public commitment scenario this group of countries will need US$ 1 per person.   
The other regions are estimated to meet their financial requirements under both scenarios.  
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Figure 9. Comparison by region of projected additional incremental MNC health expenditure and WHO costs 
of scaling up MNCH 2006 – 2015 under business as usual in million US$ (2004)  
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World Bank regions Total additional MNCH expenditure Gap WHO costs for MNCH 
Sub-Saharan Africa 9,556 -20,469 30,025 
Europe & Central Asia 1,042 622 420 
Latin America & Caribbean 23,997 16,582 7,416 
East Asia & Pacific 81,387 64,231 17,156 
Middle East & North Africa 2,162 -1,150 3,312 
South Asia 23,196 -14,545 37,741 
Table 4 the financing gap under business as usual in million US$ (2004)  
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Figure 10. Comparison by region of projected additional incremental MNC health expenditure and WHO 
costs of scaling up MNCH 2006 – 2015 under public commitments in million US$ (2004) 
World Bank regions Total additional MNCH expenditure Gap 
WHO costs for 
MNCH 
Sub-Saharan Africa 24,766 -5,260 30,025 
Europe & Central Asia 1,906 1,486 420 
Latin America & Caribbean 48,921 41,505 7,416 
East Asia & Pacific 115,234 98,078 17,156 
Middle East & North Africa 4,197 886 3,312 
South Asia 58,411 20,670 37,741 
 
Table 5 the financing gap under public commitments in million US$ (2004)   
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Figures 11 and 12 show the composition of projected total health expenditure for each country in 
the year 2015 under both scenarios. The share of external aid varies greatly amongst the 
countries; in general it is observed that under the public commitment scenario the share of private 
health expenditure is clearly reduced compared to the business as usual scenario, as a result of a 
greater share of public and external expenditure for health.   
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Figure 11. Projected sources of Total health Expenditure in 2015 under business as usual  
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Figure 12. Projected sources of Total health Expenditure in 2015 under public commitments  
4.4 Sensitivity analysis  
 
 
A one-way sensitivity analysis was used to explore the implications of uncertainty of 
assumptions.  
Changing annual GDP growth by 2 percentage points resulted in a 76 percent change in the 
financing gap. A variation of 5 percentage points in the share of maternal, neonatal and child 
health resulted in a 103 percent change in the financial gap.  When  costs increased by 50 percent, 
this widened the gap by 93 percent (table 2). 
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Table 6. Sensitivity analysis: percentage change in financial gap in response to change in 
uncertain parameters  
variable % change impact on gap 
annual GDP growth for priority 
countries 
+/- 2 percentage points -/+ 76 % 
MNCH as % of THE +/- 5 percentage points -/+ 103 % 
WHO costs + 50% + 93 % 
 
 
Table 3 presents the best and worst case results compared to the base line gap estimates (business 
as usual). It is worth noticing that under the worst case assumptions, the average of all countries 
experiences a financial gap. In particular, low income countries have a gap of more than 80 
billion US$ (more than double that derived with base line assumptions).   Under the best case 
assumptions, there is still a financial gap for the low income countries when India is not included, 
of around US$ 7.4 billion. The other income groups no longer face a gap.  
 
 
Table 7. Best and worst case analysis: impact on financial gap results   
million US$ Worst case Base line Best case 
All countries - 49,691 + 45,271 + 302,224 
Low income - 80,993 - 38,508 + 44,551 
Low income w/o India  - 57,275 - 34,341 - 7,438 
Lower middle income + 33,603 + 78,688 + 225,088 
Lower middle income w/o China - 1,197 + 13,491 + 79,655 
Upper middle - 2,300 + 5,091 + 32,585 
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5. Discussion 
 
5.1 Main results  
 
Across the countries included in this analysis, there  are differences in the likelihood that 
countries will have the financial resources to advance towards MDGs 4 and 5. In some countries 
it seems likely that adequate financial resources can be mobilized; in many countries the cost is 
far beyond domestic affordability.  Even if a combination of public and private financing seems 
likely to fill the financing gap, reliance on private financing brings with it concerns of equity, so 
additional public and external funds might be required even in this set of countries.   
 
In order to meet public commitments, general government expenditure for health in the low 
income countries would need to increase more than four fold by 2015 compared to spending 
levels in 2006; external funds would need to almost double.  
 
From the study it emerges that under the business as usual scenario, the financing gap for the 
period 2006-2015 for low income countries is more than US$ 38.5 billion. Under the public 
commitments scenario, the gap for low income countries (excluding India) falls to just under US$ 
18.3 billion. 
 
The financing gap increases each year for low income countries under both scenarios.  Over time 
lower and upper middle income countries are increasingly able to meet the costs of MNCH, with 
total health expenditure exceeding costs by a growing amount under both scenarios.  
 
Even if donor and priority countries fulfil their commitments to increase external aid to 
developing countries, Sub Saharan African countries will still lack adequate financial resources to 
scale up maternal, newborn and child health interventions. We estimate that US$ 1 per capita 
additional to committed resources would be required in 2015 to extend coverage of life-saving 
interventions for mothers and children in these countries. If total health expenditure increases in 
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line with past trends, the financing gap is estimated to be more than US$ 4 per person.  This gap 
can be taken to illustrate the relative neglect of MNCH in recent donor funding policies [17].  
 
The analysis highlights the great importance of the allocation of domestic and external resources 
to MNCH and, for external finance, across countries.  To the extent that countries and donors can 
focus their financial allocations on MNCH, this will reduce the financing gap (if at the expense of 
other health areas).  Similarly the gap will be reduced in the poorest countries if donors are able 
to target funds on the most needy country populations.   
 
5.2 Limitations  
 
Main limitations are generated by data availability and quality. We had to make critical 
assumptions such as the share of MNCH on the average of very limited data sources; in fact only 
four countries have produced NHAs that provide this figure, and two are not considered priority 
countries for our study.   Furthermore, we had to drop three countries (Somalia, Iraq and 
Zimbabwe) in our study due to lack of data and very unstable economic conditions (highly 
volatile exchange rate, extraordinary inflation rates). 
 
Results were very sensitive to estimates of cost of scaling-up MNCH.  We were reliant on the 
WHO estimates, but these are likely to be underestimates as they do not include the costs of 
increased staff salaries or building new health infrastructure.  Furthermore, the cost estimates 
were based on cost-effectiveness data which assume efficiency in the delivery of services.  This 
assumption may not apply in many low income settings.    
 
It is important to bear in mind the large extent of uncertainty around the results as shown by best 
and worst case estimates. 
 
It was not possible to present results by country due to agreement with WHO over use of 
estimated cost data. Presentation by income group could mask inter country differences 
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(particularly in the middle lower income group).  But country specific data are likely to be of 
very variable quality. 
 
Finally, this estimate should not be seen as absolute or worldwide. Other exercises would give 
different results depending upon the time frame considered, the data available and the 
assumptions made. The results presented here should therefore be interpreted in the light of the 
purpose of the analysis and in comparison with other analyses of forecasted expenditure.  Action 
at country level will need to be driven by analyses tailored to country circumstances.  
5.3 Conclusions  
 
The main implication of this analysis is that the volume of financing resources in low-income 
countries, in particular in the Sub-Saharan African region, will not be adequate to meet MDGs 4 and 
5. This group of countries is estimated to face a financing gap even under the more optimistic 
scenario; it bears the greatest amount of estimated financial requirements and enjoys the lowest 
amount of projected financing. Low income countries are likely to need complementary funding 
over and above that already committed in order to scale up provision of essential maternal, 
neonatal and child health care.  
 
The specific financing source(s) required to “fill the gap” will depend on the context and needs of 
each country and a combination of domestic and external resources is likely to be needed.  Any 
additional aid would need to be effectively targeted towards MNCH services.  
 
From the analysis it emerges that many of the priority countries – in particular the lower middle 
and upper middle income groups - are estimated to have sufficient funds for progressing towards 
MDGs 4 and 5. These countries’ own domestic policies for allocating funding and improving 
health system performance is therefore paramount. 
 
Donor countries should better target their effort to the countries that enjoy the least amount of 
resources, such as the majority of sub-Saharan African countries with low income. Moreover, 
strong coordination within the current aid architecture is critical for improving aid effectiveness 
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and for ensuring a predictable and uninterrupted flow of funding. Furthermore, development and 
strengthening of health systems is needed, because interventions cannot be delivered at scale and 
in the long term without a well functioning structure [18].  
 
Sustainable progress towards scaling up MNCH interventions will demand a willingness of both 
donors and priority countries to mobilize and then effectively channel resources to directly 
impact maternal, neonatal and under-five health care. Donor countries are required to act in 
accordance with their commitments and to coordinate their efforts for providing adequate and 
effective technical assistance, and priority countries need to be dedicated to improve and 
strengthen health systems and to better manage, plan and allocate domestic resources.   
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Annex 1 
 
Country World Bank region World Bank income
Afghanistan South Asia Low income 
Angola Sub-Saharan Africa Lower middle income 
Azerbaijan Europe & Central Asia Lower middle income 
Bangladesh South Asia Low income 
Benin Sub-Saharan Africa Low income 
Botswana Sub-Saharan Africa Upper middle income 
Brazil Latin America & Caribbean Lower middle income 
Burkina Faso Sub-Saharan Africa Low income 
Burundi Sub-Saharan Africa Low income 
Cambodia East Asia & Pacific Low income 
Cameroon Sub-Saharan Africa Lower middle income 
Central African Republic Sub-Saharan Africa Low income 
Chad Sub-Saharan Africa Low income 
China East Asia & Pacific Lower middle income 
Congo Sub-Saharan Africa Lower middle income 
Côte d'Ivoire Sub-Saharan Africa Low income 
Djibouti Middle East & North Africa Lower middle income 
Democratic Republic of the Congo Sub-Saharan Africa Low income 
Egypt Middle East & North Africa Lower middle income 
Equatorial Guinea Sub-Saharan Africa Upper middle income 
Ethiopia Sub-Saharan Africa Low income 
Gabon Sub-Saharan Africa Upper middle income 
Gambia Sub-Saharan Africa Low income 
Ghana Sub-Saharan Africa Low income 
Guinea Sub-Saharan Africa Low income 
Guinea-Bissau Sub-Saharan Africa Low income 
 35
Haiti Latin America & Caribbean Low income 
India South Asia Low income 
Indonesia East Asia & Pacific Lower middle income 
Iraq Middle East & North Africa Lower middle income 
Kenya Sub-Saharan Africa Low income 
Liberia Sub-Saharan Africa Low income 
Madagascar Sub-Saharan Africa Low income 
Malawi Sub-Saharan Africa Low income 
Mali Sub-Saharan Africa Low income 
Mauritania Sub-Saharan Africa Low income 
Mexico Latin America & Caribbean Upper middle income 
Mozambique Sub-Saharan Africa Low income 
Myanmar East Asia & Pacific Low income 
Nepal South Asia Low income 
Niger Sub-Saharan Africa Low income 
Nigeria Sub-Saharan Africa Low income 
Pakistan South Asia Low income 
Papua New Guinea East Asia & Pacific Low income 
Philippines East Asia & Pacific Lower middle income 
Rwanda Sub-Saharan Africa Low income 
Senegal Sub-Saharan Africa Low income 
Sierra Leone Sub-Saharan Africa Low income 
Somalia Sub-Saharan Africa Low income 
South Africa Sub-Saharan Africa Upper middle income 
Sudan Sub-Saharan Africa Low income 
Swaziland Sub-Saharan Africa Lower middle income 
Tajikistan Europe & Central Asia Low income 
Tanzania Sub-Saharan Africa Low income 
Togo Sub-Saharan Africa Low income 
Turkmenistan Europe & Central Asia Lower middle income 
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Uganda Sub-Saharan Africa Low income 
Yemen Middle East & North Africa Low income 
Zambia Sub-Saharan Africa Low income 
Zimbabwe Sub-Saharan Africa Low income 
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